Analysis of costs and results of prostaglandin (PGE1 alpha-cyclodestrin) therapy of peripheral arterial diseases;Analisi di costi e risultati del trattamento con prostaglandine (PGE1 alpha-ciclodestrina) in pazienti con arteriopatie periferiche.

Minerva cardioangiologica

Volumn 46, Issue 10 Suppl 1, 1998, Pages 9-15

  Bucci, M ^a   Iacobitti, P ^a   Laurora, G ^a   Cesarone, M R ^a  

^a Pierangeli Medical Center   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLODEXTRIN; FIBRINOLYTIC AGENT; PROSTAGLANDIN E1;

ARTERIOSCLEROSIS; ARTICLE; COST; COST BENEFIT ANALYSIS; DIABETIC ANGIOPATHY; GANGRENE; HUMAN; INTERMITTENT CLAUDICATION; ISCHEMIA; LEG; PERIPHERAL VASCULAR DISEASE; QUALITY OF LIFE; VASCULARIZATION;

ALPROSTADIL; ARTERIOSCLEROSIS; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; CYCLODEXTRINS; DIABETIC ANGIOPATHIES; FIBRINOLYTIC AGENTS; GANGRENE; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; LEG; PERIPHERAL VASCULAR DISEASES; QUALITY OF LIFE;

EID: 0032173474     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)